Cargando…
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache
Objective. To investigate the efficacy and safety of traditional Chinese medicine Duliang soft capsule (DSC) in prophylactic treatment for patients with chronic daily headache (CDH). Methods. A multicenter, double-blind, randomized, placebo-controlled clinical study was conducted at 18 Chinese clini...
Autores principales: | Yu, Shengyuan, Hu, Yueqing, Wan, Qi, Zhou, Jiying, Liu, Xinfeng, Qiao, Xiangyang, Yang, Xiaosu, Feng, Jiachun, Chen, Kangning, Pan, Xiaoping, Yang, Qingwu, Dou, Linsen, Liu, Ming, Chen, Yangmei, Yu, Tingmin, Yu, Juming, Li, Zhiwei, Bai, Xue, Duan, Jingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460254/ https://www.ncbi.nlm.nih.gov/pubmed/26101536 http://dx.doi.org/10.1155/2015/694061 |
Ejemplares similares
-
Elevated blood pressure and headache disorders in China – associations, under-treatment and implications for public health
por: He, Mianwang, et al.
Publicado: (2015) -
Health-care utilization for primary headache disorders in China: a population-based door-to-door survey
por: Liu, Ruozhuo, et al.
Publicado: (2013) -
Efficacy and Safety of Lasmiditan as a Novel Acute Treatment in Chinese Patients with Migraine: A Subpopulation Analysis of the Randomized Controlled Phase 3 CENTURION Trial
por: Yu, Tingmin, et al.
Publicado: (2022) -
Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial
por: Cao, Kegang, et al.
Publicado: (2016) -
Body mass index and migraine: a survey of the Chinese adult population
por: Yu, Shengyuan, et al.
Publicado: (2012)